Clinical Trial Update: Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral Palsy [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the efficacy and safety of Meditoxin for cervical dystonia in adults with cerebral palsy; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Cervical Dystonia

Drugs mentioned

• Meditoxin (botulinum toxin type A)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Adult Cerebral Palsy | Phase 4 | Status: COMPLETED